JUL 19, 2018 10:21 AM PDT

Stopping Structural Changes in Collagen may Prevent Lung Fibrosis

WRITTEN BY: Carmen Leitch

Lung fibrosis is a serious condition that thickens tissues in the lungs and makes it hard to breathe. It can be caused by a variety of environmental factors, including exposure to coal or grain dust. New work has shown that it may be possible to prevent the disease with a drug that can block structural changes to collagen. It has been suggested that it is not the amount, but rather the structure of collagen that can lead to lung fibrosis. This research, reported in eLife, has also revealed how drugs can protect against those changes. 

The architecture of our tissues is called the  extracellular matrix (ECM) and it had been thought that when that ECM accumulates, tissues get stiff and fibrosis can happen. Recent work has suggested, however, that the increase in stiffness causes more ECM material to build up, feeding a cycle that is constantly generating new scar tissue.

"We knew that stiffness is an important factor in the build-up of scar tissue in the lung," explained the lead author of this study, Mark Jones, NIHR Clinical Lecturer in Respiratory Medicine at the NIHR Southampton Biomedical Research Centre and University of Southampton, UK. "But we didn't understand what specifically causes increased stiffness in diseased human tissue. Given that excessive build-up of collagen is considered a hallmark of fibrosis, we wanted to see whether this molecule has a role in tissue stiffness."

The research team began by assessing lung tissue taken from healthy people and those with lung fibrosis to learn more about the biological and structural changes the disorder causes in that organ. The lung samples taken from fibrosis patients turned out to be far stiffer than what was taken from healthy people, but the levels of collagen were startlingly similar.
 
Next, the scientists analyzed enzymes that help crosslink collagen, which imparts its unique structure. The LOXL family is one such group of these enzymes; they were found at much higher levels in the fibrosis lung samples. 

Digging deeper, the researchers looked at collagen structure within the fibrosis samples, finding that stiffness was present wherever so-called mature cross-linked collagen levels were high. The collagen building block, called fibril, was also found to be altered in these samples. This work suggests that tissue stiffness is determined by collagen structure, which is regulated by he LOXL family.

A movie demonstrating how the effect of different treatments on tissue stiffness can be tested using patient cells which have been grown in 3D.

Knowing that, the team wanted to see if they could change collagen structure with the LOXL enzymes, and whether that could prevent lung fibrosis. LOXL-2 and LOXL-3 are blocked by an enzyme, PXS-S2A in lung cells harvested from fibrosis patients. Exposure to that drug reduced the level of cross-linked molecules in those cells. It also lowered stiffness, even at low drug concentrations. When applied to a rat model of lung fibrosis, treated rats showed no adverse impacts and had improvement in lung function and reduced fibrosis.

"Together, our results identify that treatment approaches which maintain normal collagen architecture may prevent tissue stiffening and limit the mechanisms that drive progressive fibrosis," noted Donna Davies, Professor of Respiratory Cell and Molecular Biology at the University of Southampton. "Our findings suggest the need to conduct studies in patients with lung fibrosis to see whether these approaches would be of benefit."


Sorces: AAAS/Eurekalert!, Mayo CliniceLife

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 04, 2018
Cell & Molecular Biology
AUG 04, 2018
Bioengineered Lung Successfully Grown and Transplanted
The complexity of human organs has made them difficult to engineer, but real progress is being made....
AUG 05, 2018
Genetics & Genomics
AUG 05, 2018
Newly ID'ed Lung Cell Changes Our Understanding of Disease
This rare type of cell seems to play a major role in cystic fibrosis....
AUG 12, 2018
Cell & Molecular Biology
AUG 12, 2018
A Small Set of Cells Acts as a Timekeeper
Humans have adjusted to a daily rhythm, and our bodies rely on timing....
SEP 24, 2018
Genetics & Genomics
SEP 24, 2018
Towards a Blood Test for Drowsy Driving
Driving is an everyday activity for many people around the world, and it comes with serious risks....
OCT 14, 2018
Videos
OCT 14, 2018
An Ancient Genetic Element can Help Fight Cancer
Researchers have been trying a variety of ways to boost the immune system we all have so it's able to fight off cancer....
OCT 17, 2018
Cell & Molecular Biology
OCT 17, 2018
Saving Patients From Unnecessary Chemotherapy with a Blood Test
Often, cancer patients get chemotherapy after surgery to ensure that their cancer will not come back; for many it's not needed....
Loading Comments...